GLP-1 Weight Loss Medicine: Surgical Risk Reduction
Comments Off on GLP-1 Weight Loss Medicine: Surgical Risk Reduction
June 6, 2026
GLP-1 weight loss surgical risk reduction is transforming perioperative care by lowering complications in obese patients. This medication class improves metabolic health and surgical candidacy. Clinicians must reassess surgical risk in patients on GLP-1…
Clinical Evidence for GLP-1 Receptor Agonists in Endometriosis
Comments Off on Clinical Evidence for GLP-1 Receptor Agonists in Endometriosis
May 10, 2026
GLP-1 receptor agonist endometriosis evidence highlights potential benefits in inflammation reduction and weight management. Current data remain preliminary and mostly theoretical. Clinicians should consider GLP-1 therapy as adjunctive, not primary,…